PNC Financial Services Group
DERM icon

PNC Financial Services Group’s Journey Medical DERM Stock Holding History

PNC Financial Services Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.98K Buy
1,268
+1,227
+2,993% +$7.01K ﹤0.01% 4138
2026
Q1 		$192 Sell
41
-33
-45% -$256 ﹤0.01% 5038
2025
Q4 		$571 Buy
+74
New +$580 ﹤0.01% 4804

Other funds holding DERM

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Punch & Associates Investment Management
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
Pale Fire Capital SE
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Summit Financial
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Diametric Capital
Diametric Capital Boston, Massachusetts $948M AUM 47.48% 1-Year Est. Return
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

PNC Financial Services Group's DERM Position: Q2 2026 in Review

PNC Financial Services Group increased its Journey Medical (DERM) stake by 2,993% in Q2 2026, buying an estimated $7.01K and bringing the position to 1,268 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4138.

PNC Financial Services Group first reported a position in DERM in Q4 2025 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • PNC Financial Services Group held 1,268 shares of Journey Medical worth $8.98K as of Q2 2026.
  • PNC Financial Services Group bought 1,227 Journey Medical shares in Q2 2026, an estimated $7.01K.
  • Journey Medical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4138 holding.
  • PNC Financial Services Group first reported a position in Journey Medical in Q4 2025 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.